Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;37(1):e4-e6.
doi: 10.1111/jdv.18490. Epub 2022 Aug 26.

Association of interstitial granulomatous dermatitis with messenger Rna-1273 Sars-Cov-2 vaccine

Affiliations
Free PMC article

Association of interstitial granulomatous dermatitis with messenger Rna-1273 Sars-Cov-2 vaccine

Cesare Ariasi et al. J Eur Acad Dermatol Venereol. 2023 Jan.
Free PMC article
No abstract available

Conflict of interest statement

The authors report no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Clinical Images of Interstitial granulomatous drug‐induced dermatitis‐associated with messenger RNA (mRNA)–1273 SARS‐CoV‐2 Vaccine. (a) Erythematous to violaceous plaque with annular configuration associated with multiple dome‐shape papules on the left thigh. (b) Multiple erythematous domee‐shape papules and plaques on the upper back.
FIGURE 2
FIGURE 2
Histopathologic Images of Interstitial granulomatous drug‐induced dermatitis‐associated with messenger RNA (mRNA)–1273 SARS‐CoV‐2 Vaccine. (a) Punch biopsy showing superficial dermal infiltrate. Original magnification ×2. (b) Lympho‐histiocytic infiltrate in the upper dermis and perivascular lymphocytes associated with mild interfacies damage. Original magnification ×10. (c) Particular of histiocites infiltrate in the upper dermis. Original magnification ×20. (d) Particular of interstitial infiltration with histiocytes and rare giant cells. Original magnification ×20.

Similar articles

References

    1. Bellinato F, Maurelli M, Gisondi P, Girolomoni G. Cutaneous adverse reactions associated with SARS‐CoV‐2 vaccines. J Clin Med. 2021;10(22):5344. 10.3390/jcm10225344 - DOI - PMC - PubMed
    1. Piccolo V, Bassi A, Argenziano G, Mazzatenta C, Cutrone M, Neri I, et al. BNT162b2 mRNA COVID‐19 vaccine‐induced chilblain‐like lesions reinforces the hypothesis of their relationship with SARS‐CoV‐2. J Eur Acad Dermatol Venereol. 2021;35(8):e493–4. - PMC - PubMed
    1. Magro CM, Crowson AN, Schapiro BL. The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. J Cutan Pathol. 1998;25(2):72–8. 10.1111/j.1600-0560.1998.tb01693.x - DOI - PubMed
    1. Rosenbach M, English JC. Reactive granulomatous dermatitis. Dermatol Clin. 2015;33:(3). 10.1016/j.det.2015.03.005 - DOI - PubMed
    1. Shah N, Shah M, Drucker AM, Shear NH, Ziv M, Dodiuk‐Gad RP. Granulomatous cutaneous drug eruptions: a systematic review. Am J Clin Dermatol. 2021;22(1):39–53. - PubMed

Publication types